• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软骨组织工程:我们在实践中学到了什么?

Cartilage Tissue Engineering: What Have We Learned in Practice?

作者信息

Doran Pauline M

机构信息

Faculty of Science, Engineering and Technology, Swinburne University of Technology, 218, Hawthorn, Melbourne, VIC, 3122, Australia.

出版信息

Methods Mol Biol. 2015;1340:3-21. doi: 10.1007/978-1-4939-2938-2_1.

DOI:10.1007/978-1-4939-2938-2_1
PMID:26445827
Abstract

Many technologies that underpin tissue engineering as a research field were developed with the aim of producing functional human cartilage in vitro. Much of our practical experience with three-dimensional cultures, tissue bioreactors, scaffold materials, stem cells, and differentiation protocols was gained using cartilage as a model system. Despite these advances, however, generation of engineered cartilage matrix with the composition, structure, and mechanical properties of mature articular cartilage has not yet been achieved. Currently, the major obstacles to synthesis of clinically useful cartilage constructs are our inability to control differentiation to the extent needed, and the failure of engineered and host tissues to integrate after construct implantation. The aim of this chapter is to distil from the large available body of literature the seminal approaches and experimental techniques developed for cartilage tissue engineering and to identify those specific areas requiring further research effort.

摘要

作为一个研究领域,组织工程学所依赖的许多技术都是为了在体外培育出功能性人体软骨而开发的。我们在三维培养、组织生物反应器、支架材料、干细胞和分化方案方面的许多实践经验都是以软骨作为模型系统获得的。然而,尽管取得了这些进展,但尚未成功生成具有成熟关节软骨的组成、结构和力学性能的工程化软骨基质。目前,合成临床上有用的软骨构建体的主要障碍在于我们无法在所需程度上控制分化,以及工程化组织与宿主组织在构建体植入后无法整合。本章的目的是从大量现有文献中提炼出为软骨组织工程开发的开创性方法和实验技术,并确定那些需要进一步研究的特定领域。

相似文献

1
Cartilage Tissue Engineering: What Have We Learned in Practice?软骨组织工程:我们在实践中学到了什么?
Methods Mol Biol. 2015;1340:3-21. doi: 10.1007/978-1-4939-2938-2_1.
2
Mechanobioreactors for Cartilage Tissue Engineering.用于软骨组织工程的机械生物反应器。
Methods Mol Biol. 2015;1340:203-19. doi: 10.1007/978-1-4939-2938-2_15.
3
Shear and Compression Bioreactor for Cartilage Synthesis.用于软骨合成的剪切与压缩生物反应器。
Methods Mol Biol. 2015;1340:221-33. doi: 10.1007/978-1-4939-2938-2_16.
4
Hydrogels with Tunable Properties.具有可调性质的水凝胶
Methods Mol Biol. 2015;1340:121-32. doi: 10.1007/978-1-4939-2938-2_8.
5
Feasibility of autologous bone marrow mesenchymal stem cell-derived extracellular matrix scaffold for cartilage tissue engineering.自体骨髓间充质干细胞衍生细胞外基质支架用于软骨组织工程的可行性。
Artif Organs. 2013 Dec;37(12):E179-90. doi: 10.1111/aor.12130. Epub 2013 Nov 20.
6
Preface.
Methods Mol Biol. 2015;1340:v-vi.
7
Multiphasic, Multistructured and Hierarchical Strategies for Cartilage Regeneration.用于软骨再生的多阶段、多结构和分层策略。
Adv Exp Med Biol. 2015;881:143-60. doi: 10.1007/978-3-319-22345-2_9.
8
Stratified Scaffolds for Osteochondral Tissue Engineering.用于骨软骨组织工程的分层支架
Methods Mol Biol. 2015;1340:191-200. doi: 10.1007/978-1-4939-2938-2_14.
9
Nanostructured Capsules for Cartilage Tissue Engineering.用于软骨组织工程的纳米结构胶囊
Methods Mol Biol. 2015;1340:181-9. doi: 10.1007/978-1-4939-2938-2_13.
10
Use of Interim Scaffolding and Neotissue Development to Produce a Scaffold-Free Living Hyaline Cartilage Graft.使用临时支架和新组织发育来制造无支架的活透明软骨移植物。
Methods Mol Biol. 2015;1340:153-60. doi: 10.1007/978-1-4939-2938-2_10.

引用本文的文献

1
Collagenase treatment of cartilaginous matrix promotes fusion of adjacent cartilage.胶原酶处理软骨基质可促进相邻软骨融合。
Regen Ther. 2020 Jul 28;15:97-102. doi: 10.1016/j.reth.2020.05.006. eCollection 2020 Dec.
2
In Vitro Study of Extracellular Vesicles Migration in Cartilage-Derived Osteoarthritis Samples Using Real-Time Quantitative Multimodal Nonlinear Optics Imaging.使用实时定量多模态非线性光学成像对软骨源性骨关节炎样本中细胞外囊泡迁移的体外研究
Pharmaceutics. 2020 Aug 5;12(8):734. doi: 10.3390/pharmaceutics12080734.
3
Effects of 5-aza-2´-deoxycytidine on primary human chondrocytes from osteoarthritic patients.
5-氮杂-2´-脱氧胞苷对骨关节炎患者原代人软骨细胞的影响。
PLoS One. 2020 Jun 23;15(6):e0234641. doi: 10.1371/journal.pone.0234641. eCollection 2020.
4
Lipid phosphatase SHIP-1 regulates chondrocyte hypertrophy and skeletal development.SHIP-1 脂质磷酸酶调控软骨细胞肥大和骨骼发育。
J Cell Physiol. 2020 Feb;235(2):1425-1437. doi: 10.1002/jcp.29063. Epub 2019 Jul 9.
5
Enzyme Pretreatment plus Locally Delivered HB-IGF-1 Stimulate Integrative Cartilage Repair .酶预处理加局部递送 HB-IGF-1 刺激整合性软骨修复。
Tissue Eng Part A. 2019 Sep;25(17-18):1191-1201. doi: 10.1089/ten.TEA.2019.0013. Epub 2019 Sep 3.
6
miR-134 inhibits chondrogenic differentiation of bone marrow mesenchymal stem cells by targetting SMAD6.miR-134 通过靶向 SMAD6 抑制骨髓间充质干细胞的软骨分化。
Biosci Rep. 2019 Jan 30;39(1). doi: 10.1042/BSR20180921. Print 2019 Jan 31.
7
Effects of antigen removal on a porcine osteochondral xenograft for articular cartilage repair.抗原去除对用于关节软骨修复的猪软骨异种移植物的影响。
J Biomed Mater Res A. 2018 Aug;106(8):2251-2260. doi: 10.1002/jbm.a.36411. Epub 2018 May 25.
8
Hypertrophic differentiation of mesenchymal stem cells is suppressed by xanthotoxin via the p38‑MAPK/HDAC4 pathway.花椒毒素通过p38丝裂原活化蛋白激酶/组蛋白去乙酰化酶4信号通路抑制间充质干细胞的肥大分化。
Mol Med Rep. 2017 Sep;16(3):2740-2746. doi: 10.3892/mmr.2017.6886. Epub 2017 Jun 29.
9
Genetically modified mesenchymal stromal cells in cancer therapy.癌症治疗中的基因改造间充质基质细胞。
Cytotherapy. 2016 Nov;18(11):1435-1445. doi: 10.1016/j.jcyt.2016.09.003.
10
A systems biology approach to defining regulatory mechanisms for cartilage and tendon cell phenotypes.一种用于定义软骨和肌腱细胞表型调控机制的系统生物学方法。
Sci Rep. 2016 Sep 27;6:33956. doi: 10.1038/srep33956.